Potential benefits of hyperbaric oxygen therapy on atherosclerosis and glycaemic control in patients with diabetic foot

Endokrynologia Polska

Volumn 61, Issue 3, 2010, Pages 275-279

  Karadurmus, Nuri ^a   Sahin, Mustafa ^a   Tasci, Canturk ^a   Naharci, Ilkin ^a   Ozturk, Cengiz ^b   Ilbasmis, Savas ^a   Dulkadir, Zeki ^a   Sen, Ahmet ^a   Saglam, Kenan ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Military Hospital Eskisehir   (Turkey)

Author keywords

Atherosclerosis; Diabetes; Diabetic foot; Glycaemic control; Hyperbaric oxygen therapy

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; LIPID; URIC ACID;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; DIABETIC FOOT; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERBARIC OXYGEN; INFLAMMATION; INSULIN RESISTANCE; LABORATORY TEST; LIPID ANALYSIS; MALE; OXYGEN THERAPY; PROTEIN BLOOD LEVEL; THERAPY EFFECT; THROMBOCYTE VOLUME; TREATMENT DURATION; URIC ACID BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERBARIC OXYGENATION; MALE; MIDDLE AGED;

EID: 77955615928     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Morrish NJ, Wang SL, Stevens LK et al. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44: S14-S21.
2. Almdal T, Scharling H, Jensen JS et al. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004; 164: 1422-1426.
3. Brand FN, Abbott RD, Kannel WB. Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study. Diabetes 1989; 38: 504-509.
4. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979; 2: 120-126.
5. Stamler J, Vaccaro O, Neaton JD et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444. (Pubitemid 23046633)
6. Stettler C, Allemann S, Juni P et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am Heart J 2006; 152: 27-38. (Pubitemid 43974725)
7. Wei M, Gaskill SP, Haffner SM et al. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 1998; 21: 1167-1172.
8. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409-1411.
9. Tschoepe D, Roesen P, Esser J et al. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost 1991; 17: 433-438.
10. Bonora E, Formentini G, Calcaterra F et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 2002; 25: 1135-1141.
11. Jeppesen J, Hansen TW, Olsen MH et al. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study. Eur J Cardiovasc Prev Rehabil 2008; 15: 594-598.
12. Kranke P, Bennett M, Roeckl-Wiedmann I et al. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2004: CD004123.
13. Hinchliffe RJ, Valk GD, Apelqvist J et al. A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev 2008; 24 (Suppl. 1): S119-S144.
14. Kudchodkar BJ, Pierce A, Dory L. Chronic hyperbaric oxygen treatment elicits an anti-oxidant response and attenuates atherosclerosis in apoE knockout mice. Atherosclerosis 2007; 193: 28-35. (Pubitemid 46776707)
15. Kudchodkar BJ, Wilson J, Lacko A et aL Hyperbaric oxygen reduces the progression and accelerates the regression of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 2000; 20: 1637-1643. (Pubitemid 30353899)
16. Al-Waili NS, Butler GJ, Beale J et al. Hyperbaric oxygen in the treatment of patients with cerebral stroke, brain trauma, and neurologic disease. Adv Ther 2005; 22: 659-678.
17. Belov KV, Aliab'ev VS, Shishkin EK. Results of the conservative treatment of patients with ischemia of the lower extremities by hyperbaric oxygenation. Vestn Khir Im 11 Grek 1987; 139: 43-45.
18. Kuyama T, Umemura H, Sudo T et al. Clinical studies on various therapy for the intractable trauma of toes and fingers in cases of diabetes mellitus and peripheral ischemic diseases. Nippon Geka Gakkai Zasshi 1988; 89: 763-770.
19. Reut NI, Kononova TI. Outpatient electromagnetic therapy combined with hyperbaric oxygenation in arterial occlusive diseases. Khirurgiia (Mosk) 1990; 11: 41-43.
20. Al-Waili NS, Butler GJ, Beale J et al. Influences of hyperbaric oxygen on blood pressure, heart rate and blood glucose levels in patients with diabetes mellitus and hypertension. Arch Med Res 2006; 37: 991-997.
21. Al-Waili NS, Butler GJ, Beale J et al. Hyperbaric oxygen and malignancies: a potential role in radiotherapy, chemotherapy, tumor surgery and phototherapy. Med Sci Monit 2005; 11: RA279-RA289.
22. Gill AL, Bell CN. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM 2004; 97: 385-395.
23. Kudchodkar B, Jones H, Simecka J et al. Hyperbaric oxygen treatment attenuates the pro-inflammatory and immune responses in apolipoprotein E knockout mice. Clin Immunol 2008; 128: 435-441.
24. Unfirer S, Kibel A, Drenjancevic-Peric I. The effect of hyperbaric oxygen therapy on blood vessel function in diabetes mellitus. Med Hypotheses 2008; 21.
25. Buras JA, Stahl GL, Svoboda KK et al. Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS. Am J Physiol Cell Physiol 2000; 278: C292-C30Z
26. Yin W, Badr AE, Mychaskiw G et al. Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal cerebral ischemia model. Brain Res 2002; 926: 165-171.
27. Boykin JV, Jr., Baylis C. Hyperbaric oxygen therapy mediates increased nitric oxide production associated with wound healing: a preliminary study. Adv Skin Wound Care 2007; 20: 382-388.
28. Stehouwer CD, Lambert J, Donker AJ et al. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997; 34: 55-68. (Pubitemid 27261913)
29. Demirtunc R, Duman D, Basar M et al. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complications 2008; 19.
30. Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev 2006; 22: 423-436. (Pubitemid 44774046)